ダウンロード数: 169
このアイテムのファイル:
ファイル | 記述 | サイズ | フォーマット | |
---|---|---|---|---|
33_305.pdf | 300.35 kB | Adobe PDF | 見る/開く |
タイトル: | 非淋菌性尿道炎に対するエノキサシンの使用経験 |
その他のタイトル: | Clinical experience of enoxacin in the treatment of nongonococcal urethritis |
著者: | 中野, 悦次 ![]() 市川, 靖二 ![]() 石橋, 道男 ![]() 奥山, 明彦 ![]() 松田, 稔 ![]() 高羽, 津 ![]() 園田, 孝夫 ![]() 藤岡, 秀樹 ![]() 松井, 孝之 ![]() |
著者名の別形: | NAKANO, Etsuji ICHIKAWA, Yasuji ISHIBASHI, Michio OKUYAMA, Akihiko MATSUDA, Minoru TAKAHA, Minato SONODA, Takao FUJIOKA, Hideki MATSUI, Takayuki |
キーワード: | Nongonococcal urethritis (NGU) Chlamydia trachomatis Enoxacin (ENX) |
発行日: | Feb-1987 |
出版者: | 泌尿器科紀要刊行会 |
誌名: | 泌尿器科紀要 |
巻: | 33 |
号: | 2 |
開始ページ: | 305 |
終了ページ: | 309 |
抄録: | Enoxacin (ENX) is a new derivative of pyridonecarboxylic acid and has a broad spectrum antibacterial activity. In this study, the effects of ENX on nongonococcal urethritis (NGU) were examined in 20 patients. ENX was administered orally 3 times a day at a daily dose of 600 mg for 2-23 days. Before treatment, Chlamydia trachomatis was isolated from urethral epithelium in 5 of the 20 patients. Of the 18 patients evaluated in this clinical trial, 15 (83%) responded well, and ENX was effective in 3 of the 5 Chlamydia positive cases and in 12 of the 13 Chlamydia-negative patients. As adverse reactions, headache was observed in one case and numbness of limbs in another case. No abnormality induced by ENX was recognized in laboratory findings. It is concluded that ENX is a useful drug in the treatment of patients with NGU, particularly in whom Chlamydia trachomatis is not isolated. |
URI: | http://hdl.handle.net/2433/119034 |
PubMed ID: | 3473920 |
出現コレクション: | Vol.33 No.2 |
![](/dspace/image/articlelinker.gif)
このリポジトリに保管されているアイテムはすべて著作権により保護されています。